A

· Abrams, R. & Taylor, M.A. Catatonia. A prospective clinical study. Arch. Gen. Psychiatry 1976; 33:579-581.

· Adams, F. Emergency intravenous sedation of the delirious medically ill patient. J. Clin. Psychiatry. 1988 ; 49 : 22-26.

· Aisen, P.S. & Davis, K.L. Inflammatory mechanisms in Alzheimer's disease : implications for therapy. Am. J. Psychiatry. 1994 ; 151 : 1105-1113.

· Aharon-Peretz, J. et al.Sleep-wake cycles in multi-infart dementia and dementia of the Alzheimer type. Neurology: 1991; 41/10.

· Akiskal, H.S. Mood disorders: clinical features. In Kaplan, H.I. & Sadock, B. Comprehensive Textbook of Psychiatry. 6th edn. W & W. Baltimore, 1995.

· Albert, M.S., Butters, N. & Brandt, J. Patterns of remote memory in amnesic and demented patients. Arch. Neurol. 1981 ; 38 : 495-500.

· Aldrich, M.S. Narcolepsy. Neurology: 1992; 46/6.

· Aldrich, M.S. The neurobiology of narcolepsy cataplexy. Prog. Neurobiol.: 1993; 41/5.

· Allen, A.D. & Tilkian, S.M. Depression correlated with cellular immunity in systemic immunodeficient Epstein-Barr virus syndrome (SIDES). J. Clin. Psychiatry. 1986 ; 47 : 133-135.

· Amaducci, L. La epidemiología de las demencias seniles. IX Seminario Internacional de prensa Bayer en Viena, Noviembre de 1990.

· Ambrosi, B., Gaggini, M., Moriondo, P. et al. Prolactin and sexual function. JAMA. 1980 ; 244 : 2608.

· American Psychiatric Association. Diagnostical and Statistical Manual of Mental Disorders. 3rd. edn. revised. American Psychiatric Press. Washington D.C. 1987.

· American Psychiatric Association. Diagnostical and Statistical Manual of Mental Disorders. 4th. edn. American Psychiatric Press. Washington D.C. 1994.

· Amsterdam, J.D., Henle, W., Winokur, A. et al. Serum antibodies to Epstein-Barr virus in patients with major depressive disorder. Am. J. Psychiatry. 1986 ; 143 : 1593-1596.

· Ananth, J. Impotence associated with pimozide. Am. J. Psychiatry. 1982 ; 139 : 1374.

· Andreasen, N.C., O'Leary, D.S., Cizadlo, T. et al. Remembering the past : two facets of episodic memory explored with positron emission tomography. Am. J. Psychiatry. 1995 ; 152 : 1576-1585.

· Arkonac, O. & Guze, S.B. A family study of hysteria. N. Engl. J. Med. 1963 ; 268 : 239-242.

· Arneric, S.P. et al. Cholinergic channel activators as terapeutics for CNS disorders: ABT 418 [Isoxazole hydrochloride] as a prototype to treat Alzheimer's disease. XIX CINP Congress. Washington DC. 1994.

· American Psychiatric Association. Diagnostical and Statistical Manual of Mental Disorders. 4th. edn. American Psychiatric Press. Washington D.C. 1994.

· Ardila, A. & Rosselli, M. La vejez, neuropsicología del fenómeno del envejecimiento. Ed. Prensa Creativa. 1a ed. Medellín. 1986.

· Arriagada, P.V. et al. Neurofibrillary tangles but not senile plaques parallel duration and severity of Azheimer's disease. Neurology. 1992; 42:631-639.

Principio de página

B

· Baker, H. & Hesla, P.E. La fluoxetina en el tratamiento de la cataplejia. Salud Mental. México: 1991; 14/1.

· Balon, R. et al. Sexual dysfunction during antidepressant treatment. J. Clin. Psychiatry. 1993; 54: 209.

· Barbieri, T. Sobre la categoría de género, una introducción teórica metodológica. En Directos reproductivos. Fundación Darío Chozas.

· Barnes, R., Veith, R., Okimoto, J. et al. Efficacy of antipsychotic medications in behaviorally disturbed dementia patients. Am. J. Psychiatry. 1982 ; 139 : 1170-1174.

· Barofsky, I. & Legro, M.W. Definition and measurement of fatigue. RID. 1991 ; 13 (suppl. 1) : S94-S97.

· Barsky, A.J. Wyshak, G. & Klerman, G.L. Hypochondriasis. Arch. Gen. Psychiatry. 1986; 43: 493.

· Barsky, A.J. et al. Histories of childhood trauma in adult hypochondriacal patients. Am. J. Psychiatry. 1994; 151/3.

· Bartholomew, A.A. A long-acting phenotiazine as a possible agent to control deviant sexual behavior. Am. J. Psychiatry. 1968 ; 124 : 917-922.

· Bartus, R.T., Dean, R.L., Beer, B. et al. The cholinergic hypothesis of geriatric memory dysfunction. Science. 1982 ; 217 : 408-417.

· Baumgartner, C., Podreka, I., Benda, N. et al., Postictal psychosis : a SPECT study (abstract - 21st IEC proceedings). Epilepsia. 1995 ; 36 (suppl. 3) : S218.

· Bebin, M. & Bleck, T.P. New anticonvulsant drugs. Drugs: 1994; 48/2.

· Bekkers, J.M. & Stevens, C.F. Pre-synaptic mechanism for long-term potentiation in the hippocampus. Nature. 1990 ; 346 : 724-729.

· Bennett, D. Treatment of ejaculatio praecox with monomine-oxidase inhibitors. Lancet. 1961 ; 1 : 1309.

· Bennett, R.M. The origin of myopain: An integrated hypothesis of focal muscle changes and sleep disturbance in patients with fibromyalgia syndrome. J. Musculoskelet. Pain: 1993; 1/3-4.

· Benson, F.D. Dementia in the elderly: The silent epidemic. Ann. Int. Medicine: 1982; 7:231-241.

· Berg, A.T. & Shinnar, S. Relapse following discontinuation of antiepileptic drugs : a meta-analysis. Neurology. 1994 ; 44 : 601-608.

· Beyreuther, K. La biología molecular de la enfermedad de Alzheimer. IX Seminario Internacional de prensa Bayer en Viena, Noviembre de 1990.

· Bick, P.A. & Hannah, A.L. Intramuscular lorazepam to restrain violent patients. Lancet. 1986 ; 1 : 206.

· Bliss, T.V.P. & Collingridge, G.L. A synaptic model of memory : long-term potentiation in the hippocampus. Nature. 1993 ; 361 : 31-39.

· Bodick, N. Strategies for the development of Xanomeline, a selective M1 agonist for the treatment of Alzheimer's disease. XIX CINP Congress. Washington DC. 1994.

· Boivin, D.B., Duffy, J.F., Kronauer, R.E. et al. Dose-response relationships for resetting of human circadian clock by light. Nature. 1996 ; 379 : 540-542.

· Boon, S. & Draijer, N. Multiple personality disorder in the Nederlands. Am. J. Psychiatry. 1993; 150/3.

· Bothmer, J. et al. Phosphoinositide kinasa activities in synaptosomes prepared from brains of patients with Alzheimer's disease and controls. Neurosci. Lett.: 1994; 176/2.

· Bowers, M.B., Woert, M.V. & Davis, L. Sexual behavior during L-dopa treatment for parkinsonism. Am. J. Psychiatry. 1971 ; 127 : 1691-1693.

· Bowman, E.S. & Nurnberger, J.I. Genetics of psychiatric diagnosis and treatment. In Dunner, D.L. Current Psychiatric Therapy. W.B. Saunders Company. Philadephia, 1993.

· Boyer, P.J. & Dillon, M. Factors predictive of maternal-fetal transmission of HIV-1. JAMA. 1994 ; 271 : 1925-1930.

· Bradford, A. et al. The AIDS dementia complex I. Clinical features. Annals of Neurology: 1986; 19/6.

· Branconnier, R.J. et al. Bloqueo de los mecanismos citotóxicos activados por el Ca++ en la muerte neuronal colinérgica. Boletín psicofarmacológico, Departamento de Salud y Servicios humanos de los EU: 1992; 28/2.

· Bredt, D.S. & Snyder, S.H. Nitric oxide, a novel neuronal messenger. Neuron. 1992 ; 8 : 3-11.

· Bremner, J.D., Krystal, J.H., Charney, D.S. et al. Neural mechanisms in dissociative amnesia for childhood abuse : relevance to the current controversy surrounding the "false memory syndrome". Am. J. Psychiatry. 1996 ; 153 (suppl.) : 71-82.

· Byne, W. & Parsons, B. Human sexual orientation: the biologic theories reappraised. Arch. Gen. Psychiatry.: 1993; 50/3.

Principio de página

C

· Cacabelos. Alzheimer's disease. Med. Clin.: 1992; 100.

· Caine, E.D., Grossman & Lyness. Delirium, dementia and amnestic and other cognitive disorders. In Kaplan, H.I. & Sadock, B. Comprehensive Textbook of Psychiatry. 6th edn. W & W. Baltimore, 1995.

· Callaghan, N., Gorrett, A. & Goggin, T. Withdrawal of anticonvulsivant drugs in patients free of seizures for two years. N. Engl. J. Med. 1988 ; 318 : 942-946.

· Carette, S., McCain, G.A., Bell, D.A. et al. Evaluation of amitriptyline in primary fibrositis. Arthritis Rheum. 1986 ; 29 : 655-659.

· Carney, J.M. et al. Aging and oxygen-induced modifications in brain biochemistry and behavior. Ann. N.Y. Acad. Sci. : 1994; 738.

· Carpenter, C.C., Fischl, M.A., Hammer, S.M. et al. Antiretroviral therapy for HIV infection in 1996 : Recommendations of an international panel. JAMA. 1996 ; 276 : 146-154.

· Carpenter, C.C., Fischl, M.A., Hammer, S.M. et al. Antiretroviral therapy for HIV infection in 1997 : Recommendations of an international AIDS Society-USA panel. JAMA. 1997 ; 277 : 1962-1969.

· Casals-Ariet, C. & Cullen, K. Exhibitionism treated with clomipramine. Am. J. Psychiatry. 1993 ; 150 : 1273-1274.

· Catesby, J. & Pittard, J. Aumento de sueño profundo después de uso de Trazodone. J. Clin. Psychia.: 1990; 51/9.

· Cedarbaum, J.M. & Olanow, C.W. Dopamine sulfate in ventricular cerebrospinal fluid and motor funtion in Parkinson's disease. Neurology: 1991; 41/10.

· Charney, D.S., Deutch, A.Y., Krystal, J.H. et al. Psychobiologic mechanisms of posttraumatic stress disorder. Arch. Gen. Psychiatry. 1993 ; 50 : 294-299.

· Chiveh, C.C. et al. In vivo generation of hydroxyl radicals and MPTP-induced dopaminergic toxicity in the basal ganglia. Ann. N.Y. Acad. Sci.: 1994; 738.

· Clarck, S., Campbell, S.M., Forehand, M.E. et al. Clinical characteristics of fibrositis. II. A blinded, controlled study using standard psychological tests. Arthritis Rheum. 1985 ; 28 : 132-137.

· Coccaro, E.F., Astill, J.L., Herbert, J.A. et al. Fluoxetine treatment of impulsive aggression in DSM-III-R personality disorders patients. J. Clin. Psychopharmacol. 1990 ; 10 : 373-375.

· Coccaro, E.F., Kramer, E., Zemishlany, Z. Et al. Pharmacologic treatment of noncognitive behavioral disturbances in elderly demented patients. Am. J. Psychiatry. 1990 ; 147 : 1640-1656.

· Coderch, J. Psiquiatría dinámica. 3a ed. Ed. Herder. Barcelona. 1982.

· Colenda, C.C. Buspirone in treatment of agitated demented patient. Lancet. 1988 ; 1 : 1169.

· Collacott, R.A. et al. Differential rates of psychiatric disorders in adults with Down's syndrome compared with other mentally handicapped adults. Br. J. Psychiatry: 1992; 161.

· Collier, A.C., Coombs, R., Schoenfeld, D.A. et al. Treatment for human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. N. Engl. J Med. 1996 ; 334 : 1011-1017.

· Collingride, G. Long-term potentiation in the hippocampus : mechanisms of initiation and modulation by neurotransmitters. Trends Pharmacol. Sci. 1985 ; 6 : 407-411.

· Commission on classification and terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsias and epileptic syndromes. Epilepsia. 1989 ; 30 : 389-399.

· Connor, E.M., Sperling, R.S., Gelber, R. et al. Reduction of maternal-infant transmission of human immunodeficiency virus type I with zidovudine treatment. N. Engl. J. Med. 1994 ; 331 ; 1173-1180.

· Culebras, A. Neuroanatomic and neurologic correlates of sleep disturbances. Neurology: 1992: 42/6.

· Cummings, J.L. & Benson, D.F. Subcortical dementia: review of an emerging concept. Arch. Neurol. 1984; 41: 874-879.

· Cummings, J.L., Miller, B., Hill, A. et al. Neuropsychiatric aspects of multi-infarct dementia and dementia of the Alzheimer type. Arch. Neurol. 1987 ; 44 : 389-393.

· Cummings, J.L. Depression and Parkinson's disease: A review. Am. J. Psychiatry 1992; 149: 443.

· Cummings, J.L. Neuropsychiatry: Clinical assessment and approach to diagnosis. In Kaplan, H.I. & Sadock, B. Comprehensive Textbook of Psychiatry. 6th edn. W & W. Baltimore, 1995.

· Cummings, J.L. Neuropsychiatry: Clinical assessment and approach to diagnosis. In Kaplan, H.I. & Sadock, B. Comprehensive Textbook of Psychiatry. 6th edn. W & W. Baltimore, 1995.

· Cummings, J.L. Frontal subcortical circuits and human behavior. International Congress of Neuropsychiatry (abstract). Sevilla, 1996.

Principio de página

D

· Daar, E.S., Moudgil, T., Meyer, R.D. et al. Transiet high levels of viremia in patients with primary human immunodeficiency virus type-1 infection. N. Engl. J. Med. 1991 ; 324 : 961-964.

· Dagadakis, C.S. Psychiatric emergencies. In Dunner, D.L. Current Psychiatric theraphy. W.B. Saunders Company. Philadelphia, 1993.

· Dailey, P.A., Bishop, G.D., Russell, I.J. et al. Psychological stress and the fibrositis/fibromyalgia syndrome. J. Rheumatol. 1990 ; 17 : 1380-1385.

· Dash, P.K., Hochner, B. & Kandel, E.R. Injection of the cAMP-responsive element into the nucleus of Aplysia sensory neurons blocks long-term facilitation. Nature. 1990 ; 345 : 718-721.

· Davis, K.L. et al. A double-blind placebo- controlled multicenter study of tacrine for Alzheimer's disease. New Engl. J. Med.: 1992; 327/18.

· Dawson, D. & Encel, N. Melatonin and sleep in humans. J. Pineal Res.: 1993; 15/1.

· Daza, J. Trastornos del movimiento. En Uribe, C.S. Neurología. CIB. 4a ed. Medellín. 1991.

· De Castro, R.M. Reversal of MAOI-induced anorgasmia with cyproheptadine. Am. J. Psychiatry. 1985 ; 142 : 783.

· Dehlin, O. et al. Insomnia in the geriatric patient. In Current Medical Topics: 1987.

· Delis, D.C. Neuropsychological assessment of memory disorders. In Review of Psychiatry. Vol 12. American Psychiatry Press. Washington, 1993.

· DeLisi, L.E., Nurnberger, J.I., Goldin, L.R. et al. Epstein-Barr virus and depression (letter). Arch. Gen. Psychiatry. 1986 ; 43 : 815-816.

· Drake, M.E. Jr. Conversion hysteria and dominant hemisphere lesions. Psychosomatics. 1993; 34: 524.

· Dubois, B. Frontal lobe and behavioral regulation. International Congress of Neuropsychiatry (abstract). Sevilla, 1996.

· Dudley, M.N. Clinical pharmacokinetics of nucleoside antiretroviral agents. J. Infect. Dis. 1995 ; 171 (suppl. 2) : S99-S112.

· Dunn, D.T., Newell, M.L., Ades, A.E. et al. Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet. 1992 ; 340 : 585-588.

Principio de página

E-F

· Elwes, R.D.C., Johnsosn, A.L., Shorvon, S.D. & Reynolds, E.H. The prognosis for seizure control in newly diagnosed epilepsy. N. Engl. J. Med. 1984 ; 311 : 944-947.

· Escobar, J.I. Transcultural aspects of dissociative and somatoform disorders. Psychiatr. Clin. North. Am. 1995 ; 18 : 555-569.

· Evans, D.A. et al. Prevalence of Alzheimer's disease in a community population of older persons higher than previously reported. JAMA. 1989; 262:2551-2556.

· Fallon, B.A., Javitch, J.A., Hollander, E. et al. Hypochondriasis and obsessive compulsive disorder : overlaps in diagnosis and treatment. J. Clin. Psychiatry. 1991 ; 52 : 457-460.

· Farrar, L.A. et al. Transmission and age-at-onset patterns in familial Alzheimer's disease: Evidence for heterogeneity. Neurology. 1990; 40:395.

· Feinmann, C., Harris, M. & Cawley, R. Psychogenic facial pain: presentation and treatment. Br. Med. J.: 1984; 288.

· Fernandez, F., Holmes, V.F., Adams, F. et al. Treatment of severe, refractory agitation with haloperidol drip. J. Clin. Psychiatry. 1988 ; 49 : 239-241.

· Fernando, N. Monosymptomatic hypochondriasis treated with a tricyclic antidepressant. Br. J. Psychiatry. 1988 ; 152 ; 851-852.

· Fiscus, S.A., Adimora, A.A., Schoenbach, V.J. et al. Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties. JAMA. 1996 ; 275 : 1483-1488.

· Flor-Henry, P. et al. A neuropsychological study of the stable syndrome of hysteria. Biol. Psychiatry. 1981; 16:601.

· Frank, D.A. & Greenberg, M.E. CREB : a mediator of long-term memory from mollusks to mammals. Cell. 1994 ; 79 : 5-8.

· Freinhar, J.P. & Alvarez, W.A. Clonazepam treatment of organic brain syndromes in three elderly patients. J. Clin. Psychiatry. 1986 ; 47 : 525-526.

· Frischholz, E.J. et al. Psychopathology, hypnotizability and dissociation. Am. J. Psychiatry. 1992; 149/11.

Principio de página

G

· Galasko, D., Saitoh, T., Xia, Y. et al. The alipoprotein E allele epsilon 4 is over represented in patients with the Lewy body variant of Alzheimer's disease. Neurology. 1994 ; 44 : 1950-1951.

· Gaspar, P. et al. Alterations of dopaminergic and noradrenergic innervations in motor cortex in Parkinson's disease. Ann. Neurol.: 1991; 30/3.

· Gelenberg, A.J. The catatonic syndrome. The Lancet. 1976; 1:1339-1341.

· Gelenberg, A.J. & Mendel, M.R. Catatonic reactions to high potency neuroleptic drugs. Arch. Gen. Psychiatry. 1977; 34:947.

· Gerberding, J.L. Management of occupational exposures to blood-borne viruses. N. Engl. J. Med. 1995 ; 332 : 444-451.

· Gerner, R.H. Psychiatric effects of nonpsychiatric medications. In Dunner, D.L. Current Psychiatric theraphy. W.B. Saunders Company. Philadelphia, 1993.

· Giakas, W.J., Seibyl, J.P. & Mazure, C.M. Valproate in the treatment of temper outbursts. J. Clin. Psychiatry. 1990 ; 51 : 525.

· Gillin, J.C. et al. Cholinergic receptor subtypes and REM sleep in animals and normal controls. Prog. Brain Res. : 1993; 98.

· Gillis, A. M. Sleep and the cardiovascular system. Sleep: 1993; 16/6.

· Gleason, R.P. & Schneider, L.S. Carbamazepine treatment of agitation in Alzheimer's outpatients refractory to neuroleptics. J. Clin. Psychiatry. 1990 ; 51 : 115-118.

· Goddard, G.V. Development of epileptic seizures through brain stimulation at low intensity. Nature. 1967 ; 214 : 1020-1021.

· Goldenberg, D.L. A review of the role of tricyclic medications in the treatment of fibromyalgia syndrome. J. Rheumatol. 1989 ; 16 (suppl. 19) : 137-139.

· Goldsmith, G. & Levin, J.S. Effect of sleep quality on symptoms of irritable bowel syndrome. Dig. Dis. Sci.: 1993; 38/10.

· Graham, N.M.H., Zeger, S.L., Park, L.P. et al. The effects on survival of early treatment of human immunodeficiency virus infection. N. Engl. J. Med. 1992 ; 326 : 1037-1042.

· Greenamyre, J.T. & O'Brien, C.F. N-methyl-D-aspartate antagonists in the treatment of Parkinson's disease. Arch. Neurol.: 1991; 48/9.

· Greenberg, G.V., Delgado-Escueta, A.V., Widelitz, H. et al. Juvenile myoclonic epilepsy (JME) may be linked to the BF and HLA loci on human chromosome 6. Am. J. Med. Genet. 1988 ; 31 : 185-192.

· Griffin, W.S. et al. Microglial interleukin-1 alpha expression in human head injury: correlations with neuronal and neuritic beta-amyloid precursor protein expression. Neurosci. lett.: 1994; 176/2.

· Gross, M.D. Reversal by bethanechol of sexual dysfunction caused by anticholinergic antidepressants. Am. J. Psychiatry. 1982 ; 139 : 1193-1194.

· Gualtieri, C.T. Buspirone for the behavior problems of patients with organic brain disorders. J. Clin. Psychopharmacol. 1991 ; 11 : 280-281.

Principio de página

H-I

· Haase, A.T., Henry, K., Zupancic, M. et al. Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science.1996 ; 274 : 985-989.

· Hachinski, V.C. Multi-infart dementia. Neurologic Clinics: 1983.

· Hajak, G. et al. Cerebral perfusion and metabolism during normal sleep. Nervenarzt : 1993; 64/7.

· Hall, R.C. et al. Physical illnesspresenting as psychiatric disease. Arch. Gen. Psychiatry. 1978; 35:1315.

· Hammer, S.M., Katzenstein, D.A., Hughes, M.D. et al, for the AIDS Clinical Trials Group Study 175 Study Team. A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500/µL. N. Engl. J. Med. 1996 ; 335 : 1081-1090.

· Hantz, P., Caradoc-Davies, G., Caradoc-Davies, T. et al. Depression in Parkinsosn's disease. Am. J. Psychiatry. 1994 ; 151 : 1010-1014.

· Harrison, W.M., Rabkin, J.G., Ehrhardt, A.A. et al. Effects of antidepressant medication on sexual function : A controlled study. J. Clin. Psychopharmacol. 1986 ; 6 : 144-149.

· Hawkins, R.D. & Schacher, S. Identified facilitator neurons are excited by cutaneous stimuli used in dishabituation, sensitization, and classical conditioning of Aplysia. J. Neurosci. 1989 ; 9 : 4236-4245.

· Henrard, D.R., Phillips, J.F., Muenz, L.R. et al. Natural history of HIV-1 cell-free viremia. JAMA. 1995 ; 274 : 554-558.

· Hernández-Peon, R., Scherrer, H. & Jouvet, M. Modification of electrical activity in cochlear nucleus during "attention" in unanesthetized cats. Science. 1956 ; 123 : 331.

· Hershey, L.A. et al. Tremor at onset. Arch. Neurol.: 1991; 48/10.

· Ho, D.D., Neumann, A.U., Perelson, A.S. et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature. 1995 ; 373 : 123-126.

· Hollister, L.E. Adverse reactions to phenotiazines. JAMA. 1964 ; 189 : 311-313.

· Holmes, G.P. Defining the chronic fatigue syndrome. RID. 1991 ; 13 (suppl. 1) : S53-S55.

· Hudson, J.I. & Pope, H.G. Fibromyalgia and psychopathology : Is fibromyalgia a form of "affective spectrum disorder" ? J. Rheumatol. 1989 ; 16(suppl. 19) : 15-22.

· Hyman, S.E. Acute Psychoses and catatonia. In Brown, L. Manual of Psychiatric emergencies. 2nd ed. 1988.

· Hyman, B.T. Down syndrome and Alzheimer disease. Prog. Clin. Biol. Res. 1992 ; 379 : 123-142.

Principio de página

J-K

· Janet, P. The major symptoms of hysteria. 2nd edn. McMillan Co. N.Y., 1924.

· Jenner, P. The rationale for the use of dopamine agonists in Parkinson's disease. Neurology: 1995; 45/3.

· Jeste, D.V., Wragg, R.E., Salmon, D.P. et al. Cognitive deficits with Alzheimer's disease with and without delusions. Am. J. Psychiatry. 1992 ; 149 : 184-189.

· Jones, R.M. Factitious disorders. In Kaplan, H.I. & Sadock, B. Comprehensive Textbook of Psychiatry. 6th edn. W & W. Baltimore, 1995.

· Josiassen, R.C. et al. Development of neuropsychological deficits in Huntington's disease. Arch. Neurol.: 1983; 40.

· Kafka, M.P. & Prentky, R. Fluoxetine treatment of nonparaphilic sexual addictions and paraphilias in men. J. Clin. Psychiatry.: 1992; 53/10.

· Kahn, J.D., Lagakos, S.W., Richman, D.D. et al. A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. N. Engl. J. Med. 1992 ; 327 : 581-587.

· Kandel, E.R. & Hawkins, R.D. The biological basis of learning and individuality. Sci. Am. 1992 ; 267 : 53-60.

· Kandel, E.R. Brain and behavior. In Essentials of neural science and behavior. Kandel, E.R., Schwartz, J.H. & Jessell, T.M. (eds.). Appleton & Lange. Connecticut, 1995.

· Karon, J.M., Rosenberg, P.S., McQuillan, G. et al. Prevalence of HIV Infection in the United States, 1984 to 1992. JAMA. 1996 ; 276 : 126-131.

· Katlama, C., Ingrand, D., Loveday, C. et al. Safety and efficacy of lamivudine-zidovudine combination therapy in antirretroviral-naive patients : a randomized controlled comparison with zidovudine monotherapy. JAMA. 1996 ; 276 : 118-125.

· Katzman, R. Alzheimer's disease. N. Engl. J. Med. 1986 ; 314 : 964-973.

· Kachaturian, Z.S. Envejecimiento cerebral y calcio. Modern Geriatrics: 1992;4/4.

· Kachaturian, Z.S. Homeostásis cálcica y envejecimiento cerebral. IX Seminario Internacional de prensa Bayer en Viena, Noviembre de 1990.

· Kandel, E.R. Brain and behavior. In Essentials of neural science and behavior. Kandel, E.R., Schwartz, J.H. & Jessell, T.M. (eds.). Appleton & Lange. Connecticut, 1995.

· Khatoon, S. et al. Guanosine triphosphate binding to beta-subunit of tubulin in Alzheimer's disease brain: role of microtubule-associated protein tau. J. Neurochem. : 1995; 64/2.

· Kilby, J.M. & Saag, M.S. Treatment of HIV-1 infection : an overview of new strategies and novel agents. Infect. Med. 1996 ; 13 : 903-911.

· Kirmayer, L.J., Young, A. & Hayton, B.C. The cultural context of anxiety disorders. Psychiatr. Clin. North. Am. 1995 ; 18 : 503-521.

· Knapp, M.J. et al. A 30-week randomized controlled tria of high-dose Tacrine in patients with Alzheimer's disease. JAMA: 1994; 271/13.

· Kokmen, E. et al. Clinical risk factors for Alzheimer's disease. Neurology: 1991; 41/9.

· Komaroff, A.L. & Buchwald, D. Symptoms and signs of chronic fatigue syndrome. RID. 1991 ; 13 (suppl. 1) : S8-S11.

· Kotin, J., Wilbert, D.E. & Verburg, D. Thioridazine and sexual dysfunction. Am. J. Psychiatry. 1976 : 133 : 82-85.

Principio de página

L

· Lal, S., Nair, N.P.V., Cervantes, P. et al. Effect of naloxone or levallorphan on serum prolactin concentrations and apomorphine-induced growth hormone secretion. Acta Psychiatr. Scand. 1979 ; 59 : 173-179.

· Lebert, F., Pasquier, F. & Petit, H. Behavioral effects of trazodone in Alzheimer's disease. J. Clin. Psychiatry. 1994 ; 55 : 536-538.

· Lees, A.J. & Stern, G.M. Pergolide and lisuride for levodopa-induced oscillations. Lancet. 1981 ; 1 : 577.

· Lees, A.J. & Smith, E. Cognitive deficits in the early stages of Parkinson's disease. Brain: 1983; 106.

· Leibenluft, E. Do gonadal steroids regulate circadian rhythms in humans? J. Affect. Disord.: 1993; 29/2-3.

· Levy, J.A. The transmission of HIV and factors influencing progression to AIDS. Am. J. Med. 1993 ; 95 : 86-100.

· Levy, J.K., Dubinsky, S., Newmark, M.E. et al. Characteristics of depressive symptomatology in seizure disorder patients (abstract - 21st IEC proceedings). Epilepsia. 1995 ; 36 (suppl. 3) : S218.

· Lewis-Fernández, R. & Kleinman, A. Cultural psychiatry : theoretical, clinical, and research issues. Psych. Clin. North. Am. 1995 ; 18 : 433-447.

· Li, G., Silverman, J.M., Smith, C.J. et al. Age at onset and familial risk in Alzheimer's disease. Am.J. Psychiatry. 1995 ; 152 : 424-430.

· Lin, H.J., Myers, L.E., Yen-Lieberman, B. et al. Multicenter evaluation of quantification methods of plasma human immunodeficiency virus type 1 RNA. J. Infect. Dis. 1994 ; 170 : 553-562.

· Lindhout, D. & Omzigt, J.G. Teratogenic effects of antiepileptic drugs : implications for the management of epilepsy in women of childbearing age. Epilepsia. 1994 ; 35 (suppl. 4) : S19-S28.

· Lipowski, Z.J. Somatization: The concept and its clinical application. Am.J. Psychiatry. 1988; 145:1358.

· Livingston, G. et al. Does sleep disturbance predict depression in elderly people? A study in inner London. Br. J. Gen. Pract. : 1993; 43/376.

· Llinás, R. Avances en neurociencias. XXXIII Congreso Nacional de Psiquiatría. Cali, 1994.

· Ludwig, A.M. Hysteria : a neurobiological theory. Arch. Gen. Psychiatr. 1972 ; 27 : 771-777.

· Lugaresi, E. The thalamus and insomnia. Neurology: 1992: 46/6.

Principio de página

M-N

· Mahowald, M.W. & Schenck, C.H. Dissociated states of wakefulness and sleep. Neurology: 1992; 42/6.

· Malinow, R. & Miller, J. P. Postsynaptic hyperpolarization during conditioning reversibly blocks induction of long-term potentiation. Nature. 1986 ; 321 : 529-530.

· Malinow, R., Schulman, H. & Tsien, R.W. Inhibition of postsynaptic PKC or CaMKII blocks induction but not expression of LTP. Science. 1989 ; 245 : 862-864.

· Mann, S.C. et al. Lethal Catatonia. Am. J. Psychiatry. 1986; 143:1374-1381.

· Mannen, T. et al. A multi-center, double-blind study on slow-release bromocriptine in the treatment of Parkinson's disease. Neurology: 1991; 41/10.

· Manu, P., Matthews, D.A., Lane, T.J. et al. Depression among patients with a chiefcomplaint of chronic fatigue. J. Affect. Disord. 1989 ; 17 : 165-172.

· Mattes, J.A. Carbamazepine vs propranolol for rage outbursts. Psychopharamcol. Bull. 1988 ; 24 : 179-182.

· Mattsonm R.H., Cramer, J.A., Collins, J.F. et al. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. N. Engl. J. Med. 1992 ; 327 : 765-771.

· Mattson, M.P. & Furukawa, K. Short precursor shortens memory. Nature. 1997 ; 387 : 457-458.

· Mauskopf, J.A., Paul, J.E., Wichman, D,S. et al. Economic impact of treatment of HIV-positive pregnant women and their newborns with zidovudine. JAMA. 1996 ; 276 : 132-138.

· Mayberg, H.S. et al. Paralimbic frontal lobe hypometabolism in depression associted with Huntington's disease. Neurology. 1992; 42: 1791.

· Mayer, M.L., Westbrook, G.L. & Guthrie, P.B. Voltage-dependent block by of NMDA responses in spinal cord neurones. Nature. 1984 ; 309 : 262-263.

· McDonald, R.L. & Kelly, K.M. Antiepileptic drug mechanisms of action. Epilepsia. 1993 ; 34 (suppl. 5) : S1-S8.

· McDonald, R.L. & Kelly, K.M. Mechanisms of action of currently prescribed and newly development antiepileptic drugs. Epilepsia. 1994 ; 35 (suppl. 4) : S41-S50.

· McKeith, I.G. et al. An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of the Lewy body type. Neurology. 1994; 44: 872.

· McNamara, J.O. Cellular and molecular basis of epilepsy. J. Neurosci. 1994 ; 14 : 3413-3425.

· McNaughton, B.L., Douglas, R.M. & Goddard, G.V. Synaptic enhancement in fascia dentata : cooperativity among coactive afferents. Brain Res. 1978 ; 157 : 277-293.

· Mellors, J.W., Kinsley, L.A., Rinaldo, C.R.J. et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann. Intern. Med. 1995; 122 : 573-579.

· Mellors, J.W., Rinaldo, C.R. Jr., Gupta, P. et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 1996 ; 272 : 1167-1170.

· Messenheimer, J.A. Lamotrigine. Epilepsia. 1995 ; 36 (suppl. 2) : S87-S94.

· Mesulam, M.M. Behavioural anatomy of human frontal lobes. International Congress of Neuropsychiatry (abstract). Sevilla, 1996.

· Mielke, R. et al. HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia; comparison of perfusion and metabolic pattern. Eur. J. Nucl. Med. : 1994; 21/10.

· Miller, A.H., Silberstein, C., Asnis, G.M. et al. Epstein-Barr virus infection and depression (letter). J. Clin. Psychiatry. 1986 ; 47 : 529.

· Mishkin, M. Memory in monkeys severely impaired by combined but not separate removal of amygdala and hippocampus. Nature. 1978 ; 173 : 297-298.

· Mohs, R.C. & Cohen, L. Alzheimer's Disease Assessment Scale (ADAS). Psychopharmacol. Bull. 1988 ; 24 : 627-628.

· Montarolo, P.G., Goelet, P., Castellucci, V.F. et al. A critical period for macromolecular synthesis in long-term heterosynaptic facilitation in Aplysia. Science. 1986 ; 234 : 1249-1254.

· Monteiro, W.O., Noshirvani, H.F., Marks, I.M. et al. Anorgasmia from clomipramine in obsessive-compulsive disorder : A controlled-trial. Br. J. Psychiatry. 1987 ; 151 : 107-112.

· Morin, C.M., Culbert, J.P. & Schwartz, S.M. Nonpharmacological interventions for insomnia : A meta-analysis of tretament efficacy. Am. J. Psychiatry. 1994 ; 151 : 1172-1180.

· Morris, R.G.M., Anderson, E., Lynch, G.S. et al. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, APV. Nature. 1986 ; 319 : 774-776.

· Moskowitz, A.S. & Altshler, L. Increased sensivity to lithium-induced neurotoxicity after stroke : a case report. J. Clin. Psychopharmacol. 1991 ; 11 : 272-273.

· Moss, M.B., Albert, M.S., Butters, N. et al. Differential patterns of memory loss among patients with Alzheimer's disease, Huntington's disease and alcoholic Korsakoff's syndrome. Arch. Neurol. 1986 ; 43 : 239-246.

· Murphy, R. Clinical aspects of human immunodeficiency virus disease : clinical rationale for treatment. J. Infect. Dis. 1995 ; 171(suppl. 2) : S81-S87.

· Nemeroff, C.B. & Krishnan, R.R. Hormonal regulation of behavior. In Dunner, D.L. Current Psychiatric theraphy. W.B. Saunders Company. Philadelphia, 1993.

· Nemiah, J.C. Dissociative disorders. In Kaplan, H.I. & Sadock, B. Comprehensive Textbook of Psychiatry. 6th edn. W & W. Baltimore, 1995.

· Nininger, J.E. Inhibition of ejaculation by amitriptyline. Am. J. Psychiatry. 1978 ; 135 : 750-751.

· Nowak, L., Bregestovski, P., Ascher, P. et al. Magnesium gates glutamate-actived channels in mouse central neurones. Nature. 1984 ; 307 : 462-465.

· Nurnberg, H.G. & Levine, P.E. Spontaneus remission of MAO-I induced anorgasmia. Am. J. Psychiatry. 1987 ; 144 : 805-807.

Principio de página

O-P

· O'Brien, C.P., DiGiancomo, J.N., Fahn, S. et al. Mental effects on high-dosage levodopa. Arch. Gen. Psychiatry. 1971 ; 24 : 61-64.

· O'Brien, T.R., Blattner, W.A., Waters, D. et al. Serum HIV-1 RNA levels and time to development of AIDS in the multicenter hemophilia cohort study. JAMA. 1996 ; 276 : 105-110.

· O'Brien, W.A., Hartigan, P.M., Martin, D. et al. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. N. Engl. J. Med. 1996 ; 334 : 426-431.

· Oeschner et al. Cognitive impairment, dementia and psychosocial funtioning in human inmunodeficiency virus infection. Acta Psychiatr. Scand.: 1993; 87/1.

· Onuma, T., Adachi, N., Ishida, S. et al. Prevalence and annual incidence of psychoses in patients wiyh epilepsy (abstract - 21st IEC proceedings). Epilepsia. 1995 ; 36 (suppl. 3) : S218.

· Osuna, E. Enfoque del paciente con trastorno del sueño. Lab. Boehringer Ingelheim. 1993.

· Osuna, E. & Rubiano, A. El sueño y sus trastornos. Prensa Moderna Impresores.Bogotá. 1992.

· Osuna, E. & Rubiano, A. Principios de la medicina del sueño. Lab. Upjohn. 1994.

· Ott, A., Breteler, M.M.B., van Harskamp, F. et al. Prevalence of Alzheimer's disease and vascular dementia : association with education. The Rotterdam study. BMJ. 1995 ; 310 : 970-973.

· Ottman, R., Risch, N., Hauser, W.A. et al. Localization of a gene for partial epilepsy to chromosome 10q. Nature Genet. 1995 ; 10 : 56-60.

· Ownby, R.L., Sevush, S. & Eisdorfer, C. Behavioral subtypes of Alzheimer's disease : a replication. International Congress of Neuropsychiatry (abstract). Sevilla, 1996.

· Pan American Health Organization. 1992 AIDS, HIV and STD Annual Surveillance report for the region of the Americas. Washington, DC : Pan American Health Organization, 1994.

· Pan American Health Organization. AIDS Surveillance in the Americas : Quarterly Report. Washington, DC : Pan American Health Organization, 1995.

· Parkes, J.D. & Schachter, M. Clomipramine and clonazepam in cataplexy. Lancet. 1979 ; 2

· Parsa, M.A., Szigethy, E., Voci, J.M. et al. Risperidone in treatment of choreoathetosis of Huntington's disease (letter). J. Clin. Psychopharmacol. 1997 ; 17 : 134-135.

· Pellock, J.M. Efficacy and adverse effects of antiepileptic drugs. Pediatr. Clin. North Am. 1989 ; 36 : 435-448.

· Penn, H., Racy, J., Lapham, L. et al. Catatonic behavior, viral encephalopathy, and death. The problem of fatal catatonia. Arch. Gen. Psychiatry. 1972 ; 27 : 758-761.

· Perry, E.K. et al. Necropsy evidence of central cholinergic deficits in senile dementia. Lancet. 1977; 1:189.

· Perry, S. et al. Severity of psychiatric symptoms after HIV testing. Br. J. Psychiatry: 1993;162.

· Phillips, H.A., Scheffer, I.E., Berkovis, S.F. et al. Localization of a gene for autosomal dominant nocturnal frontal lobe epilepsy to chromosome 20q 3.2. Nature Genet. 1995 ; 10 : 117-118.

· Piatak, M.J., Saag, M.S., Yang, L.C. et al. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science. 1993 ; 259 : 1749-1754.

· Pillay, D., Lipman, M.C., Lee, C.A. et al. A clinicopathological audit of opportunistic viral infections in HIV-infected patients. AIDS. 1993 ; 7 : 969-974.

· Pilowsky, I. Dimensions of hypochondriasis. Br. J. Psychiatry. 1967 ; 113 : 89-93.

· Pinner, E. & Rich, C.L. Effects of trazodone on agressive behavior in seven patients with organic mental disorders. Am. J. Psychiatry. 1988 ; 145 : 1295-1296.

· Poewe, W. Dopamine agonists in the treatment of Parkinson's disease. Neurology: 1995; 45/3.

· Post, R.M. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am. J. Psychiatry. 1992; 149 (8)

Principio de página

Q-R

· Ratey, J.J., Leveroni, C.L., Miller, A.C. et al. Low-dose buspirone to treat agitation and maladaptative behavior in brain-injured patients : two case reports. J. Clin. Psychopharmacol. 1992 ; 12 : 362-364.

· Reifler, B.V., Teri, L., Raskind, M. et al. Double-blind trial of imipramine in Alzheimer's disease patients with and without depression. Am. J. Psychiatry. 1989 ; 146 : 45-49.

· Reisberg, B., Borestein, J., Salob, S.P. et al. Behavioral symptoms in Alzheimer's disease : phenomenology and treatment. J. Clin. Psychiatry. 1987 ; 48 (suppl. 5) : 9-15.

· Reisberg, B. Aspectos clínicos del envejecimiento del SNC y de la demencia. IX Seminario Internacional de prensa Bayer en Viena, Noviembre de 1990.

· Rogers, D. The motor disorders of severe psychiatric illness: a conflict of paradigms. Br. J. Psychiatry. 1985; 147:221-232.

· Rosselli, M. Amnesias asociadas con demencias. En Neuropsicología de la memoria, Ardila, A., Montañes, P. & Rosselli, M. (eds.). De. Prensa Creativa, Medellín, 1985.

· Russell, I.J., Bowden, C.L., Michalek, J. et al. Imipramine receptor density on platelets of patients with fibrositis syndrome correlation with disease severity and response to therapy. Arthritis Rheum. 1987 ; 30 : S63.

Principio de página

S

· Sadock, V.A. Normal human sexuality and sexual dysfunctions. 1995. In Kaplan, H.I. & Sadock, B. Comprehensive Textbook of Psychiatry. 6th edn. W & W. Baltimore, 1995.

· Sanford, J.P., Sande, M.A. & Gilbert, D.N. Guide to HIV/AIDS therapy. 5th edn. 1996.

· Segraves, R.T. Reversal by bethanecol of imipramine-induced ejaculatory dysfunction. Am. J. Psychiatry. 1987 ; 144 : 1243.

· Segraves, R.T. Effects of psychotropic drugs on human erection and ejaculation. Arch. Gen. Psychiatry. 1989 ; 46 : 275-284.

· Seward, J.P. Estrés profesional. En Medicina Laboral de Joseph La Dou. Ed. Manual Moderno. México. 1993.

· Shapiro, W.R. Treatment of cataplexy with clomipramine. Arch. Neurol. 1975 ; 32 : 653-656.

· Shinnar, S., Berg, A.T., Moshe, S.L. et al. Discontinuing antiepileptic drugs in children with epilepsy : a prospective study. Ann. Neurol. 1994 ; 35 : 534-545.

· Shinnar, S. & Berg, A.T. Withdrawal of antiepileptic drugs. Current Opinion in Neurology. 1995 ; 8 : 103-106.

· Shiwach, R. Psychopathology in Huntington's disease patients. Acta Psychiatr. Scand. 1994 ; 90 : 241-246.

· Silverman, J.M., Li, G., Zaccario, M.L. et al. Patterns of risk in first degree relatives of Alzheimer's disease patients. Arch. Gen. Psychiatry. 1994 ; 51 : 577-586.

· Singh, H. Therapeutic use of thioridazine in premature ejaculation. Am. J. Psychiatry. 1963 ; 119 : 891.

· Sommadossi, J-P. Comparison of metabolism and in vitro antiviral activity of Stavudine versus other 2',3'-dideoxynucleoside analogues. J. Infect Dis. 1995 ; 171 (suppl. 2) : S88-S92.

· Sorscher, S.M. & Dilsaver, S.C. Antidepressant-induced sexual dysfunction in men : Due to cholinergic blockade ? J. Clin. Psychopharmacol. 1986 ; 6 : 53-55.

· Sovner, R. Anorgasmia associated with imipramine but not desipramine : Case report. J. Clin. Psychiatry. 1983 ; 44 : 345-346.

· Sovner, R. Treatment of tricyclic antidepressant-induced orgasmic inhibition with cyproheptadine. J. Clin. Psychopharmacol. 1984 ; 4 : 169.

· Starreveld, E. et al. Double-blind cross-over placebo controlled study of flunarizine in patients with therapy resistant epilepsy. Can. J. Neurol. Scien. : 1989; 16/2.

· Staszewski, S., Loveday, C., Picazo, J.J. et al. Safety and efficacy of lamivudine-zidovudine combination therapy in zidovudine-experienced patients : a randomized controlled comparison with zidovudine monotherapy. JAMA. 1996 ; 276 : 111-117.

· Staubli, U. & Lynch, G. Stable hippocampal long-term potentiation elicited by "thetha" pattern stimulation. Brain Res. 1987 ; 435 : 227-234.

· Steele, T.E. & Howell, E.F. Cyproheptadine for imipramine-induced anorgasmia. J. Clin. Psychopharmacol. 1986 ; 6 : 326-327.

· Stefoski, D. et al. 4-Aminopyridine in multiple sclerosis. Neurology: 1991; 41/9.

· Steriade, M. Basic mechanisms of sleep generation. Neurology: 1992; 46/6.

· Stern, M. et al. The epidemiology of Parkinson's disease. Ann. Neurol.: 1991; 48/9.

· Stone, A.B. Treatment of hypochondriasis with clomipramine. J. Clin. Psychiatry. 1993 ; 54 : 200-201.

· Straus, S.E. The chronic mononucleosis syndrome. J. Infect. Dis. 1988 ; 157 : 405-412.

· Straus, S.E. History of chronic fatigue syndrome. RID. 1991 ; 13 (suppl. 1) : S2-S7.

· Sultzer, D.L. et al. A comparison of psychiatry symptoms in vascular dementia and Alzheimer's disease. Am. J. Psychiatry 1993; 150: 1806.

· Swanson, D.W., Moore, G.L. & Nobrega, F.T. Family history of alcoholism in patients with chronic fatigue. J. Clin. Psychiatry. 1978 ; 39 : 754-755.

Principio de página

T-U-V

· Tiller, J.W.G., Dakis, J.A. & Shaw, J.M. Short-term buspirone tratment in desinhibition with dementia. Lancet. 1988 ; 2 :510.

· Tokars, J.I., Marcus, R., Culver, D.H. et al. Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood. Ann. Intern. Med. 1993 ; 118 : 913-919.

· Torres, Y. & Montoya, I.D. Segundo Estudio Nacional de Salud Mental y Consumo de Sustancias Psicoactivas. Ministerio de Salud de Colombia. Santafé de Bogotá D.E., 1997.

· Trimble, M.R., Schmitz, E.B., Moriarty, J. et al. Psychiatric profiles and pattern of cerebral blood flow in patients with focal epilepsies (abstract - 21st IEC proceedings). Epilepsia. 1995 ; 36 (suppl. 3) : S218.

· Trzepacz, P.T. Delirium : advances in diagnosis, pathophysiology, and treatment. Psych. Clin. N.A. 1996 ; 19 : 429-446.

· Tune, L.E., Strauss, M.E., Lew, M.F. et al. Serum levels of anticholinergic drugs and impaired recent memory in chronic achizophrenic patients. Am. J. Psychiatry. 1982 ; 139 : 1460-1461.

· Uribe, C.S. Parkinsonismo y enfermedad de Parkinson. En Neurología. CIB. 4a ed. Medellín. 1991a.

· Uribe, C.S. Las epilepsias. En Neurología. CIB. 4a ed. Medellín. 1991b.

· Vallejo, J. Casos Clínicos de Psiquiatría. Ed. Salvat. 1991.

· Volberding, P.A., Lagakos, S.W., Koch, M.A. et al. Zidovudine in asyntomatic human immunodeficiency virus infection : a controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. N. Engl. J. Med. 1990 ; 322 : 941-949.

· Volberding, P.A., Lagakos, S.W., Grimes, J.M. et al. The duration of zidovudine benefit in persons with asymptomatic HIV infection. JAMA. 1994 ; 272 : 437-442.

· Von Korff, M. & Resche, L.L. First onset of common pain symptoms: A prospective study of depression as a risk factor. Pain. 1993; 55:251.

Principio de página

W-Y

· Waldinger, M.D., Hengeveld, M.W. & Zwinderman, A.H. Paroxetine treatment of premature ejaculation : double-blind, randomized, placebo-controlled study. Am. J. Psychiatry. 1994 ; 151 : 1377-1379.

Wawrose, F.E. & Sisto, T.M. Clomipramine and a case of exhibitionism. Am. J. Psychiatry. 1992 ; 149 : 843.

· Wechsler, A.F. et al. Pick's disease.Arch. Neurol.: 1982; 39.

· Whitehouse, P.J. & Voci, J. Therapeutic trials in Alzheimer's disease. Current Opinion in Neurology. 1995 ; 8 : 275-278.

· Whitlock, F.A. The aetiology of hysteria. Acta Psychiatr. Scand. 1967 ; 43 : 144-162.

· Wilson, L.G. Consultation-liason psychiatry. In Dunner, D.L. Current psychiatric therapy. WB Saunders Company. Philadelphia, 1993.

· Woerner, P.I & Guze, S.B. A family and marital study of hysteria. Br. J. Psychiatry. 1968 ; 114 : 161-168.

· World Health Organization. International Classification of Diseases. Revision 10. Geneva. 1992.

· Wragg, R.E. & Jeste, D.V. Overview of depression and psychosis in Alzheimer's disease. Am. J. Psychiatry 1989; 146: 577-587.

· Yanker, B.A., Duffy, L.K. & Kirschner, D.A. Neurotrophic and neurotoxic effects of amyloid b-protein : reversal by tachykinin neuropeptides. Science. 1990 ; 250 : 279-282.

· Yesavage, J.A. et al. Development of aphasia, apraxia and anoxia and decline in Alzheimer's disease. Br. J. Psychia.: 1993; 162.

· Young, J.P.R., Fenton, G.W. & Lader, M.H. The inheritance of neurotic traits : a twin study of the Middlesex Hospital Questionaire. Br. J. Psychiatry. 1971 ; 119 : 393-398.

· Yudofsky, S.C., Silver, J.M. & Hales, R.E. Treatment of agressive disorders. In Schatzberg, A. & Nemeroff, C.B. (eds.) Textbook of psychopharmacology. American Psychiatric Press. Washington, 1995.

Principio de página

Z

· Zal, H.M. Síndrome de fatiga crónica. Psychiatry Today: 1993; 3/2.

· Zola-Morgan, S.M. & Squire, L.R. The primate hippocampal formation : evidence for a time-limited role in memory storage. Science. 1990 ; 250 : 288-290.

Principio de página

Comentarios             Principio de página